Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stag

The nonclinical study conducted at Stony Brook University adds to substantial evidence of activity a

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulati

Multi-omics analyses identifies linoleic acid as a critical fatty acid which is modulated by ART26.1

The presentations include results from the Phase 1 clinical study of ART26.12 as well as new biomark

First-in-Human Results Demonstrate Favorable Safety and Pharmacokinetics Profile AI Aided Target Eng

Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage

U.S. stocks traded mixed, Nasdaq down 0.3%. Dow up 0.59%, S&P 500 down 0.09%. Consumer discretio

US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, en

Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro

Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, COD

Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(4.00) per share which missed the ana

https://www.sec.gov/Archives/edgar/data/1621221/000164033426000820/artl_s3.htm

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulatin

Artelo Biosciences, Inc. (NASDAQ:ARTL) shares jumped on Monday after the company announced the publi

Demonstrates ART26.12's Differentiated Profile as a Promising Pain Treatment Ahead of Planned Mu

A look at the most-searched tickers on Benzinga Pro for the month of March shows several newcomers a

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its s

U.S. stock futures up, Dow gains 150 points. Avis Budget Group (CAR) shares fall 9.6% in pre-market.

PMGC Holdings shares surged 100.6% to $3.35 in pre-market trading after announcing a licensing agree

U.S. stocks down, NASDAQ drops 1.5% on Friday. Energy shares up, consumer discretionary down. Univer

Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced that it has entered into definitive agreemen

US stocks lower as Dow falls 400+ points on Friday. Dow down 0.89%, NASDAQ falls 1.27%, S&P 500

Artelo Biosciences Inc. shares are trading higher Friday after withdrawing its SEC Registration Stat

Shares of Navan Inc (NASDAQ: NAVN) spiked in pre-market trading on better-than-expected Q4 results.

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulati

Artelo Biosciences, Inc. (NASDAQ:ARTL) is drawing increased attention following its expansion into t

AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Amplig

Artelo Biosciences shares jump after a glaucoma study deal to test ART27.13, a new treatment targeti

US stocks traded lower this morning with the Dow falling more than 150 points. Energy shares climbed

Artelo Biosciences (NASDAQ:ARTL) has announced its entry into the ophthalmology space with a fully f

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulati